Low bone mineral density in a man with recurrent minimal trauma fractures: a cauTIOnary tale of unrecognised hypophosphataemia
Sign Up to like & getrecommendations! Published in 2018 at "Internal Medicine Journal"
DOI: 10.1111/imj.13980
Abstract: Osteoporosis affects over 1 million Australians and is due to reduced bone mass and disruption of bone microarchitecture resulting in increased risk of fracture. Osteomalacia may also present with low bone mineral density (BMD) and… read more here.
Keywords: bone mineral; fracture; hypophosphataemia; low bone ... See more keywords
Hypoplastic amelogenesis imperfecta, bilateral nephrolithiasis and FGF-23-mediated hypophosphataemia: a triad of FAM20A-related enamel renal syndrome
Sign Up to like & getrecommendations! Published in 2022 at "BMJ Case Reports"
DOI: 10.1136/bcr-2022-250514
Abstract: Enamel renal syndrome (ERS) due to loss of function (LOF) mutation of FAM20A gene typically consists of hypoplastic amelogenesis imperfecta (AI) and bilateral nephrolithiasis/nephrocalcinosis. Recent evidence suggests that FAM20A interacts with FAM20C and increases its… read more here.
Keywords: hypophosphataemia; fgf mediated; mediated hypophosphataemia; fam20a ... See more keywords
Severe hypophosphataemia following ferric carboxymaltose infusion in paediatric patients with inflammatory bowel disease
Sign Up to like & getrecommendations! Published in 2019 at "Frontline Gastroenterology"
DOI: 10.1136/flgastro-2019-101242
Abstract: This case series describes the cases of three adolescent patients with established inflammatory bowel disease (IBD) who experienced significant hypophosphataemia following intravenous infusion of ferric carboxymaltose as treatment for iron deficiency anaemia. Hypophosphataemia may cause… read more here.
Keywords: hypophosphataemia following; bowel disease; infusion; inflammatory bowel ... See more keywords
Hypophosphataemia following ferric derisomaltose and ferric carboxymaltose in patients with iron deficiency anaemia due to inflammatory bowel disease (PHOSPHARE-IBD): a randomised clinical trial
Sign Up to like & getrecommendations! Published in 2022 at "Gut"
DOI: 10.1136/gutjnl-2022-327897
Abstract: Objective Intravenous iron—a common treatment for anaemia and iron deficiency due to inflammatory bowel disease (IBD)—can cause hypophosphataemia. This trial compared the incidence of hypophosphataemia after treatment with ferric carboxymaltose (FCM) or ferric derisomaltose (FDI).… read more here.
Keywords: iron deficiency; fcm; hypophosphataemia; trial ... See more keywords
Hypophosphataemia following ferric carboxymaltose and ferric derisomaltose: case closed, but questions remain
Sign Up to like & getrecommendations! Published in 2023 at "Gut"
DOI: 10.1136/gutjnl-2023-330061
Abstract: We read with interest the paper by Zoller et al comparing the rate of hypophosphataemia with ferric carboxymaltose (FCM) versus ferric derisomaltose (FDI) infusions in patients with inflammatory bowel disease (IBD). The higher rate of… read more here.
Keywords: fcm; iron; hypophosphataemia; ferric carboxymaltose ... See more keywords